About Molecular Response
Molecular Response is a company based in San Diego (United States) founded in 2010 was acquired by Bioduro in March 2018. It operates as a B2B. Molecular Response operates in a competitive market with competitors including GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Molecular Response
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecular Response
Molecular Response has secured backing from 1 investor. Prominent investors backing the company include Bioduro. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Integrated drug discovery and development services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecular Response
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molecular Response
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecular Response Comparisons
Competitors of Molecular Response
Molecular Response operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| domain | founded_year | HQ Location |
Provider of a biorepository of human clinical specimens
|
|
| domain | founded_year | HQ Location |
Human biological materials for research are supplied via a biorepository.
|
|
| domain | founded_year | HQ Location |
Provider of biobanking services for life sciences industries
|
|
| domain | founded_year | HQ Location |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
|
| domain | founded_year | HQ Location |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Molecular Response
When was Molecular Response founded?
Molecular Response was founded in 2010.
Where is Molecular Response located?
Molecular Response is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
What does Molecular Response do?
Molecular Response, founded in 2010 in San Diego, United States, focuses on providing healthcare solutions, advancing biotech innovations, biobanking, and biospecimen storage. Specializes in biospecimen storage and tumor biobanking services. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Who are the top competitors of Molecular Response?
Molecular Response's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Who are Molecular Response's investors?
Molecular Response has 1 investor. Key investors include Bioduro.